Filing Analysis
Ribbon Acquisition Corp. (a SPAC) entered into a definitive Business Combination Agreement on June 30, 2025, to merge with DRC Medicine Inc., a company specializing in AI-powered allergy and infection diagnostic kits and protective face masks.
🚩 Red Flags
- SPAC transaction complexity involving multiple jurisdictions (Cayman Islands, Japan, Delaware).
- Redemption risk: The final share count depends on the 'Redemption Price' at closing, which is subject to shareholder redemptions.
📋 Key Facts
- Agreement date: June 30, 2025
- Target Company: DRC Medicine Inc. (Delaware) and DRC Medicine Ltd. (Japan)
- Transaction Structure: Share exchange followed by domestication from Cayman Islands to Delaware, then a merger with a subsidiary of PubCo.
- Equity Value: The Aggregate Merger Consideration is based on an equity value of $350,000,000.
- Consideration Ratio: To be determined by dividing the Equity Value by the Redemption Price at the time of closing.
- Target Business: Design and manufacture of AI-powered allergy/infection diagnostic kits and protective face masks.
Ribbon Acquisition Corp. has announced the separation of its units into Class A ordinary shares and rights, which began trading on March 7, 2025. This allows unit holders to trade the underlying components separately under new Nasdaq symbols.
📋 Key Facts
- Units (RIBBU) consist of one Class A Ordinary Share and one Right.
- Class A Ordinary Shares are now trading under symbol 'RIBB' on Nasdaq.
- Rights are now trading under symbol 'RIBBR' on Nasdaq, with each right entitling the holder to 1/7th of a Class A Ordinary Share.
- Trading for separated components commenced on March 7, 2025.
- Unit holders must contact transfer agent Odyssey Trust Company to separate units.
Ribbon Acquisition Corp. successfully consummated its initial public offering (IPO) and a simultaneous private placement on January 16, 2025. The company raised gross proceeds of $50 million from the public and $2.2 million from its sponsor.
📋 Key Facts
- Consummated IPO of 5,000,000 units at $10.00 per unit on January 16, 2025.
- Public Unit composition: One Class A ordinary share and one Right (entitling holder to 1/7 of an Ordinary Share).
- Private placement of 220,000 units with Sponsor (Ribbon Investment Company Ltd) at $10.00 per unit.
- Total gross proceeds from IPO and Private Placement: $52,200,000.
- $50,000,000 of net proceeds deposited into a trust account with Odyssey Trust Company.
Ribbon Acquisition Corp. has successfully completed its initial public offering (IPO) and private placement, raising a total of $52.2 million in gross proceeds. The company is a SPAC (Special Purpose Acquisition Company) that has established a trust account to fund a future business combination.
🚩 Red Flags
- SPAC structure inherently carries high risk regarding the ultimate target identification and business combination success.
📋 Key Facts
- Completed IPO of 5,000,000 units at $10.00 per unit, generating $50,000,000 in gross proceeds.
- Consummated private placement of 220,000 units with Sponsor (Ribbon Investment Company Ltd) at $10.00 per unit, generating $2,200,000.
- Total net proceeds deposited into a trust account as of January 16, 2025, is $50,000,000 (net IPO/Private Placement funds).
- Each Public Unit consists of one Class A ordinary share and one right to receive 1/7th of an ordinary share upon business combination.
- Appointed three new directors: James Zhao-Hui Zhang, Kani Chen, and Jon Nathan Miller.